Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments and Licenses - Schedule of Pro Forma (Details)

v3.4.0.3
Acquisitions, Investments and Licenses - Schedule of Pro Forma (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2015
USD ($)
Bio Reference  
Business Acquisition [Line Items]  
Revenues $ 238,917
Net loss (124,662)
Net loss attributable to common shareholders (123,736)
EirGen  
Business Acquisition [Line Items]  
Revenues 32,904
Net loss (118,915)
Net loss attributable to common shareholders $ (117,990)